Answer
Reported events with epoetin alfa and other erythropoiesis-stimulating agents include venous and arterial thromboses and embolism (sometimes fatal), deep venous thrombosis, pulmonary emboli, retinal thrombosis, myocardial infarction, and cerebrovascular accidents including cerebral infarction, cerebral haemorrhage and transient ischaemic attacks.
Sources for this answer
- Eprex 40,000 IU/ml solution for injection in pre-filled syringeJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.4 Special warnings and precautions for use · Version 20Document updated
Sources checked